BioLife Solutions SEC Filings

Type
Report
Date
4Insidertransaktion3/9/2026
144144-Formular3/9/2026
4Insidertransaktion3/5/2026
4Insidertransaktion3/5/2026
4Insidertransaktion3/5/2026
4Insidertransaktion3/5/2026
4Insidertransaktion3/5/2026
4Insidertransaktion3/5/2026
144144-Formular3/5/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/2/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
4Insidertransaktion2/26/2026
10-KJahresbericht2/26/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/26/2026
SCHEDULE 13G/ASCHEDULE 13G/A-Formular2/12/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/12/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/9/2026
4Insidertransaktion1/8/2026
4Insidertransaktion1/8/2026
4Insidertransaktion1/8/2026
4Insidertransaktion1/8/2026
4Insidertransaktion1/8/2026
SCHEDULE 13G/ASCHEDULE 13G/A-Formular1/8/2026
4Insidertransaktion12/17/2025
4Insidertransaktion12/17/2025
4Insidertransaktion12/17/2025
4Insidertransaktion12/17/2025
4Insidertransaktion12/17/2025
4Insidertransaktion12/17/2025
144144-Formular12/15/2025
4Insidertransaktion12/5/2025
144144-Formular12/4/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/28/2025
4Insidertransaktion11/21/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/17/2025
4Insidertransaktion11/13/2025
144144-Formular11/13/2025
144144-Formular11/12/2025
144144-Formular11/12/2025
144144-Formular11/12/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/6/2025
10-QQuartalsbericht11/6/2025
4Insidertransaktion10/28/2025
4Insidertransaktion10/24/2025
144144-Formular10/22/2025
4Insidertransaktion10/22/2025
4Insidertransaktion10/20/2025
SCHEDULE 13D/ASCHEDULE 13D/A-Formular10/17/2025
4Insidertransaktion10/17/2025
144144-Formular10/16/2025
144144-Formular10/15/2025
4Insidertransaktion10/14/2025
4Insidertransaktion10/14/2025
4Insidertransaktion10/14/2025
4Insidertransaktion10/14/2025
4Insidertransaktion10/14/2025
4Insidertransaktion9/17/2025
4Insidertransaktion9/15/2025
144144-Formular9/15/2025
4Insidertransaktion9/15/2025
4Insidertransaktion9/15/2025
4Insidertransaktion9/15/2025
4Insidertransaktion9/15/2025
4Insidertransaktion9/15/2025
4Insidertransaktion8/28/2025
4Insidertransaktion8/28/2025
4Insidertransaktion8/28/2025
4Insidertransaktion8/28/2025
4Insidertransaktion8/28/2025
4Insidertransaktion8/28/2025
4Insidertransaktion8/27/2025
144144-Formular8/25/2025
4Insidertransaktion8/21/2025
SCHEDULE 13D/ASCHEDULE 13D/A-Formular8/21/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/21/2025
144144-Formular8/15/2025
SCHEDULE 13GSCHEDULE 13G-Formular8/14/2025
SCHEDULE 13D/ASCHEDULE 13D/A-Formular8/13/2025
4Insidertransaktion8/13/2025
144144-Formular8/11/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/7/2025
10-QQuartalsbericht8/7/2025
4Insidertransaktion7/22/2025

BioLife Solutions Documents 2026

This page contains all official documents and SEC filings for BioLife Solutions stock (BLFS, ISIN: US09062W2044). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of BioLife Solutions's regulatory filings.

BioLife Solutions Stock analysis

BioLife Solutions BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry.